4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pluri Inc. (PLUR) operates in the Biotechnology industry and is headquartered in Haifa, Israel with about 92 employees. Its market capitalization is roughly $16 million. In the fiscal year ended 2026-06-30, PLUR reported $1M in revenue and ($24M) in net income.
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries.
Interactive charts & full statements → Open the PLUR valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $1M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $1M | $0M | $0M | — |
| Operating Income (EBIT) | ($25M) | ($25M) | ($22M) | ($22M) | ($27M) | — |
| Net Income | ($24M) | ($24M) | ($23M) | ($21M) | ($28M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($6M) | ($6M) | ($6M) | ($7M) | — |
| Net Income | ($6M) | ($6M) | ($6M) | ($6M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets | $25M | $39M | $40M | $51M | — |
| Total Liabilities | $42M | $40M | $34M | $36M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PLUR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms